Has Henry Hirsch, MD received payments from drug or device companies?

Yes. Drug and device makers reported $53,233 in general payments to Henry Hirsch, MD across 330 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Henry Hirsch, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Henry Hirsch, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Henry Hirsch, MD

Surgery · Philadelphia, PANPI 1750727665

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $36,800 of the $53,233 with a category attached, or 69.1%. Endologix LLC accounts for 70.4% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $20,797, more than ten times the $477 reported in 2019. Among surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,233in general payments, 2019–2025

Across 330 payments — averaging $161.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Endologix LLC$37K
Cagent Vascular Inc$6K
Boston Scientific$4K
Cook Medical LLC$920
Silk Road Medical, Inc.$829
Bolton Medical Inc$579
plus $4K from 25 others

What the payments were for

Consulting fees$36,80069%
Speaking & faculty fees$4001%
Travel & lodging$3,3396%
Food & beverage$12,47323%
Education$2210%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Endologix LLC	145	$37,475
Cagent Vascular Inc	12	$6,054
Boston Scientific	54	$3,855
Cook Medical LLC	22	$920
Silk Road Medical, Inc.	9	$829
Bolton Medical Inc	5	$579
Terumo Medical Corporation	4	$456
BD	2	$424
Medtronic(2 entities)	13	$414
W. L. Gore & Associates, Inc.	11	$413
Penumbra, Inc.	3	$282
Johnson & Johnson(2 entities)	11	$268
Bard Peripheral Vascular, Inc.	3	$244
Surmodics, Inc.	8	$176
Abbott	1	$146
Cardiovascular Systems Inc.	2	$129
AbbVie	3	$74
Resmed Corp	3	$66
Angiodynamics, Inc.	3	$63
Inari Medical, Inc.	1	$60
Solventum Corporation	2	$46
Biocomposites Inc	1	$45
Tactile Systems Technology Inc	2	$37
KCI USA, Inc.	2	$37
Takeda Pharmaceuticals U.S.A., Inc.	1	$25
Siemens Medical Solutions USA, Inc.	1	$24
Shockwave Medical, Inc	1	$22
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$22
Lemaitre Vascular, Inc.	2	$20
Urgo Medical North America, LLC	1	$14
Integra Lifesciences Corporation	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AFX2 Bifurcated Endograft System$17,828
Torus Stent Graft System$13,501
ENDOCROSS Device$13,501
Serrantor$5,800
AngioJet Ultra 5000A$2,224
Alto Abdominal Stent Graft System$1,846
ENROUTE Transcarotid Neuroprotection System$920
ENROUTE Transcarotid Stent$672
ENHANCE Transcarotid Peripheral Access Kit$419
GLIDESHEATH SLENDER$350
TREO ABDOMINAL STENT-GRAFT SYSTEM$346
ENROUTE .014 Guidewire$314
Endurant$152
AFX2$151
Ovation$151
ESPRIT$146
ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$143
Vascular Graft$133
GENERAL VASCULAR INTERVENTION$128
LUTONIX$128

How this compares

$53,233 in reported general payments places this provider in the 95th percentile of 1,424 surgery providers in Pennsylvania.

See all surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$241,733

Medicare patients

812

Services billed

1,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	44	$490

Paid to pharmacies, not to this prescriber.

Other surgery in Philadelphia

Brett ChatmanPhiladelphia$178K
David WernsingPhiladelphia$142K
Said AzouryPhiladelphia$131K
James MarkmannPhiladelphia$97K
Daniel HewittPhiladelphia$89K
Daniel HashimotoPhiladelphia$73K
Scott KozinPhiladelphia$59K
Prashanth PalvannanPhiladelphia$54K
Erica PettkePhiladelphia$52K
Evan NadlerPhiladelphia$46K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →